| Symbol |
Name |
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
|
|
GNAI3
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
|
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNAZ
|
guanine nucleotide binding protein (G protein), alpha z polypeptide
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRIA3
|
glutamate receptor, ionotropic, AMPA 3
|
|
GRID2
|
glutamate receptor, ionotropic, delta 2
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1
|
|
GUCY1A2
|
guanylate cyclase 1, soluble, alpha 2
|
|
GUCY1B1
|
guanylate cyclase 1 soluble subunit beta 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JMJD7-PLA2G4B
|
JMJD7-PLA2G4B readthrough
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
NANOS1
|
nanos homolog 1 (Drosophila)
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G4B
|
phospholipase A2, group IVB (cytosolic)
|
|
PLA2G4C
|
phospholipase A2, group IVC (cytosolic, calcium-independent)
|
|
PLA2G4D
|
phospholipase A2, group IVD (cytosolic)
|
|
PLA2G4E
|
phospholipase A2, group IVE
|
|
PLA2G4F
|
phospholipase A2, group IVF
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific)
|
|
PLCB4
|
phospholipase C, beta 4
|
|
PPP1R17
|
protein phosphatase 1, regulatory subunit 17
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2CB
|
protein phosphatase 2, catalytic subunit, beta isozyme
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PPP2R1B
|
protein phosphatase 2, regulatory subunit A, beta
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRKG2
|
protein kinase, cGMP-dependent, type II
|
|
RNASE3
|
ribonuclease, RNase A family, 3
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|